<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02440386</url>
  </required_header>
  <id_info>
    <org_study_id>HRECREF:849/2014</org_study_id>
    <nct_id>NCT02440386</nct_id>
  </id_info>
  <brief_title>iLink (Incentives for Linkage to ART) Study: A Mixed-methods Study to Improve Linkage to HIV Care</brief_title>
  <acronym>iLink</acronym>
  <official_title>iLink (Incentives for Linkage to ART) Study: A Mixed-methods Study to Improve Linkage to HIV Care</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Cape Town</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Brown University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Cape Town</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The iLink Study examines whether a Conditional Economic Incentive (CEI) may be an effective
      tool for improving linkage to HIV treatment and care following referral for antiretroviral
      therapy (ART) services from a mobile health clinic in Cape Town, South Africa. The study
      examines the feasibility and acceptability of using a R300 (approximately $25 as of April
      2015) voucher - that is exchanged for cash upon initiation of ART within 3 months - to
      increase the uptake of ART among men and women living in low-income areas. This pilot study
      (n=64) includes a randomised control trial, follow-up telephone calls and medical record
      reviews, and in-depth interviews.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The initiation of combination antiretroviral therapy (ART) remains a serious challenge
      globally, and particularly in South Africa, the country with the largest population of people
      living with HIV worldwide (UNAIDS 2012). South Africa has the largest ART programme globally,
      yet only half of those needing ART in South Africa were receiving treatment in 2011 (Johnson
      2012). Early initiation of ART improves treatment outcomes and reduces AIDS-related morbidity
      and mortality. Recent studies have demonstrated a secondary benefit of ART in preventing HIV
      transmission by reducing viral load and thus transmissibility (Cohen et al. 2011; Montaner et
      al. 2010; Tanser et al. 2013). Despite the personal and public health benefits of ART, South
      African studies have shown large loss to follow-up at each of the stages required for ART
      initiation: (1) initial CD4 count testing and returning for results; (2) attending ART
      readiness counselling; and (3) returning to initiate ART (April et al. 2009; Bassett et al.
      2010; Kranzer et al. 2010; Larson et al. 2010; Losina et al. 2010).

      Novel interventions are urgently needed to improve linkage to HIV treatment and care
      post-diagnosis, as increased ART coverage will reduce AIDS-related morbidity and mortality,
      and HIV incidence. Improving ART coverage is therefore a priority in many regions of the
      world, and particularly in sub-Saharan Africa, where AIDS remains a key development
      challenge. Interventions based on theories from the field of behavioural economics, a hybrid
      of principles from psychology and economics (Bickel et al. 1995), have great potential to
      help strengthen the contributions of psychology to improving ART outcomes. Conditional
      economic incentives (CEIs), a financial incentive given upon completion of an outcome that
      can be objectively measured (i.e. ART initiation), has the potential to leverage two
      theoretical principles from behavioural economics to improve ART initiation. First, instead
      of being completely rational and accurate, decision-making is viewed as inherently biased due
      to a multitude of social-cognitive and affective factors that play a role in cost-benefit
      analysis, such as emotions, personal beliefs, and contextual factors (Fiske &amp; Taylor 2008).
      In other words, people's preferred outcomes are largely determined by salient contextual
      needs (Operario et al. 2013). Second, people have a tendency to give greater value to rewards
      in the present or near future than those in the more distant future (a phenomenon economists
      term temporal discounting) and therefore decision-making favours immediate rewards and
      heavily discounts future outcomes. This poses a challenge for ART initiation as the future
      benefits of ART may be valued less than an individual's more immediate needs, especially for
      individuals who currently perceive themselves to be relatively healthy.

      A CEI may help overcome this challenge for ART initiation by increasing its immediate
      benefits. A CEI may therefore help 'nudge' individuals to initiate ART by altering the
      cost-benefit ratio so that the benefits of ART (i.e. the immediate financial reward and the
      future health reward) outweigh the immediate costs of ART initiation, such as transport, time
      off work, long waiting lines and the fear of stigma. The application of CEIs to address HIV
      prevention and treatment problems is still in its infancy, but they have been successfully
      employed to improve adherence to ART (Rosen et al. 2007; Sorensen et al. 2007; Javanbakht et
      al. 2010), increase HIV testing uptake and the collection of HIV tests results (Thornton
      2008), and reduce risky sexual behaviours (Baird et al. 2012). This evidence indicates that
      small incentives-based interventions can 'nudge' individuals towards adopting healthier
      behaviours.

      The proposed research will make a significant contribution to our knowledge about demand
      creation for HIV treatment and prevention services by examining whether CEIs may also be an
      effective tool for improving linkage to HIV treatment and care following referral for ART
      services. The proposed research will examine the feasibility and acceptability of using CEIs
      to increase the uptake of ART among men and women who are referred for ART services. Our
      long-term collaborative goal is to utilize the results from this pilot study to prepare a
      grant application for a fully-powered RCT examining whether CEIs can increase ART initiation.

      Objectives To examine the acceptability and feasibility of an incentive intervention aimed at
      increasing uptake of ART among men and women who are referred for ART (CD4 &lt; 500 or WHO stage
      4) by a mobile health clinic.

      Acceptability

        -  Did participants find the randomization process fair and acceptable?

        -  Was the intervention an incentive that motivated or encouraged uptake of ART?

        -  Was the incentive amount and type acceptable?

        -  Were individuals in the control arm discouraged from ART initiation because they felt
           that their linkage to care efforts were not rewarded?

        -  Were there cases of patients who were unsatisfied or disappointed as a consequence of
           the study (eg. they did not receive the incentive, yet they thought they should)?

      Feasibility

        -  Is it possible to recruit men and women into the study on the day of being referred for
           ART?

        -  Is it possible to track individuals and recruit individuals for in-depth interviews?

        -  Is it possible to implement the study as planned:

             -  Did the randomization process work?

             -  Did participants understand the incentive system?

             -  Did participants believe that they would actually receive the incentive?

             -  Did the incentive delivery method work?

        -  What is the potential for individuals to game the incentive system? Did any individuals
           find a method of receiving the money without starting ART?

      Potential Efficacy

        -  Is ART initiation more likely among men and women who are offered the incentive compared
           to men and women who are not offered the incentive?

        -  Is early ART initiation more likely among men and women who are offered the incentive
           compared to men and women who are not offered the incentive?

        -  Does retention in care after ART initiation differ among men and women who are offered
           the incentive compared to men and women not offered the incentive?

        -  What is the potential for incentives to improve ART initiation given participants
           behavioural intentions regarding ART initiation and barriers to ART initiation?
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>April 2015</start_date>
  <completion_date type="Anticipated">November 2016</completion_date>
  <primary_completion_date type="Actual">July 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>ART initiation</measure>
    <time_frame>3 months</time_frame>
    <description>Commencement of antiretroviral therapy for HIV</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to ART initiation</measure>
    <time_frame>1-52 weeks</time_frame>
    <description>Days between referral for ART and ART initiation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Linkage to Care: first visit to clinic</measure>
    <time_frame>3 months</time_frame>
    <description>Self-reported attendance at an HIV/ART clinic within 3 months of study enrollment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to linkage to care</measure>
    <time_frame>1-52 weeks</time_frame>
    <description>Days between referral for ART and attendance at an HIV/ART clinic</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ART retention</measure>
    <time_frame>12 months</time_frame>
    <description>Indicator of whether the participant collected his/her ART 1 year after starting treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Feasibility - accrual percentage</measure>
    <time_frame>6 months</time_frame>
    <description>Number of people enrolled in study/number approached for enrollment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Feasibility - participant tracking</measure>
    <time_frame>3 and 6 months post enrolment</time_frame>
    <description>Number of participants contact at 3 and 6 months/number of participants enrolled</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Acceptability - adverse events</measure>
    <time_frame>6 months</time_frame>
    <description>Unexpected risks/harms of providing incentives as self-reported by participants</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">87</enrollment>
  <condition>HIV</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The control arm receives standard of care. Standard of care involves referral for ART services and follow-up calls (maximum of 6) to assess whether linkage to care has occurred.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Incentive</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The incentive arm receives standard of care plus a R300 voucher. The R300 voucher can be exchanged for cash if the participant starts ART at any clinic of their choice within three months from study enrollment.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Conditional economic incentive</intervention_name>
    <description>Individuals in the intervention arm will receive the standard of care. In addition, individuals in the intervention arm receive a voucher worth R300. They are told that they will get this money if they:
Initiate ART at any clinic within 3 months from the time of their CD4 count test at the Tutu Tester; and
send a text message to the study team to let us know they have started ART;
Schedule a meeting with a member of the study team to show their clinic card and ARVs to confirm ART initiation.</description>
    <arm_group_label>Incentive</arm_group_label>
    <other_name>CEI</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Referred for ART by the Tutu Tester Mobile Clinic (CD4 â‰¤ 500 or WHO stage 4)

          -  Planning to live in the study area for the next 6 months

          -  Willing and able to provide written informed consent for study participation

          -  Willing to accept calls from the study staff

        Exclusion Criteria:

          -  Participated in the study previously

          -  Previously been on ART

          -  Intoxicated at the time of enrolment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Brendan Maughan-Brown, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Cape Town</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Omar Galarraga, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Brown University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Tutu Tester Mobile Clinic, Desmond Tutu HIV Foundation</name>
      <address>
        <city>Cape Town</city>
        <state>Western Cape</state>
        <zip>7705</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>South Africa</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 24, 2015</study_first_submitted>
  <study_first_submitted_qc>May 6, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 12, 2015</study_first_posted>
  <last_update_submitted>October 14, 2016</last_update_submitted>
  <last_update_submitted_qc>October 14, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 17, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Cape Town</investigator_affiliation>
    <investigator_full_name>Brendan Maughan-Brown</investigator_full_name>
    <investigator_title>Dr</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

